Search details
1.
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
N Engl J Med
; 384(12): 1089-1100, 2021 03 25.
Article
in English
| MEDLINE | ID: mdl-33761206
2.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Lancet
; 399(10337): 1779-1789, 2022 05 07.
Article
in English
| MEDLINE | ID: mdl-35378077
3.
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
AIDS Behav
; 27(9): 3027-3037, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-36929319
4.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV
; 9(5): e309-e322, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35489376
5.
Health system challenges affecting HIV and tuberculosis integration at primary healthcare clinics in Durban, South Africa.
Afr J Prim Health Care Fam Med
; 11(1): e1-e7, 2019 May 09.
Article
in English
| MEDLINE | ID: mdl-31170790
6.
Health system challenges affecting HIV and tuberculosis integration at primary healthcare clinics in Durban, South Africa
Afr. j. prim. health care fam. med. (Online)
; 11(1): 1-7, 2019. ilus
Article
in English
| AIM | ID: biblio-1257657
Results
1 -
6
de 6
1
Next >
>>